Barriers to reporting of adverse drugs reactions: a cross sectional study among community pharmacists in United Kingdom
- PMID: 28943977
- PMCID: PMC5597805
- DOI: 10.18549/PharmPract.2017.03.931
Barriers to reporting of adverse drugs reactions: a cross sectional study among community pharmacists in United Kingdom
Abstract
Background: Adverse Drug Reactions (ADRs) are a major public health problem. Prompt reporting of suspected ADRs is fundamental in the post-marketing surveillance of medicines and helps in ensuring medicine safety. However, fewer ADRs are reported in general and in particular by community pharmacists. There is limited knowledge about the factors which are preventing community pharmacists in the UK from reporting an ADR.
Objectives: To identify the barriers to ADR reporting among community pharmacists practicing in the UK.
Methods: A cross sectional study using a 25-items questionnaire (both online and paper based) including 10 barriers to ADR reporting was conducted from 1st April 2012 to September 2012. Community pharmacists practicing in the West Midlands, UK, were approached for the participation in this study. Chi-Square and regression were applied to identify covariates for the barriers to ADR reporting. A significant value of 0.05 was assigned for analysis.
Results: Of the 230 invited community pharmacists, 138 pharmacists responded (response rate 60%). The median age of respondents was 31 years. All pharmacists reported that they would report both serious and mild ADRs from drugs with black triangle among children as well as adults. About 95% (n=131) of the pharmacists were familiar with the paper based ADR reporting system. Store-based pharmacists were more likely to be more confident about which ADRs to report [0.680, 95% Confidence Interval 0.43-3.59]. Lack of time 46.4% (n=64), and pharmacists perception that ADR is not serious enough to report (65.2%; n=90) were identified as barriers to ADR reporting. Majority 63.0% (n=87) of the pharmacists identified training and information about what to report and access to Information Technology (IT) (For example access to internet connection) 61.6% (n=85) as facilitators to ADR reporting process.
Conclusion: Lack of time and ADRs considered not serious enough by pharmacists to report were barriers to ADR reporting. Further training and education about the types of ADRs to be reported can help to improve the reporting of ADRs.
Keywords: Adverse Drug Reaction Reporting Systems; Attitude of Health Personnel; Pharmacies; Pharmacists; Professional Practice; Regression Analysis; Surveys and Questionnaires; United Kingdom.
Conflict of interest statement
CONFLICT OF INTEREST All authors declare no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.
Similar articles
-
Exploring the community pharmacist's knowledge, attitude, and practices regarding adverse drug reactions and its reporting in the United Arab Emirates: a survey-based cross-sectional study.Ther Adv Drug Saf. 2024 Oct 7;15:20420986241285930. doi: 10.1177/20420986241285930. eCollection 2024. Ther Adv Drug Saf. 2024. PMID: 39381061 Free PMC article.
-
A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain.Drug Saf. 2000 Aug;23(2):165-72. doi: 10.2165/00002018-200023020-00006. Drug Saf. 2000. PMID: 10945377
-
A national survey of knowledge, attitude, practice, and barriers towards pharmacovigilance and adverse drug reaction reporting among hospital pharmacy practitioners in the United Arab Emirates.J Pharm Policy Pract. 2023 Jul 18;16(1):92. doi: 10.1186/s40545-023-00593-6. J Pharm Policy Pract. 2023. PMID: 37464445 Free PMC article.
-
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200. Health Technol Assess. 2011. PMID: 21545758 Review.
-
Reporting, Monitoring, and Handling of Adverse Drug Reactions in Australia: Scoping Review.JMIR Public Health Surveill. 2023 Jan 16;9:e40080. doi: 10.2196/40080. JMIR Public Health Surveill. 2023. PMID: 36645706 Free PMC article.
Cited by
-
Community pharmacists' skills and practice regarding dispensing fiscalized substances: a cross-sectional survey.Front Pharmacol. 2023 Aug 31;14:1237306. doi: 10.3389/fphar.2023.1237306. eCollection 2023. Front Pharmacol. 2023. PMID: 37719848 Free PMC article.
-
UK veterinary professionals' perceptions and experiences of adverse drug reaction reporting.Vet Rec. 2022 Sep;191(6):e1796. doi: 10.1002/vetr.1796. Epub 2022 Jun 3. Vet Rec. 2022. PMID: 35665513 Free PMC article.
-
Identifying strategies to improve adverse drug reporting through key informant interviews among community pharmacists in a developing country.Sci Rep. 2024 Jul 22;14(1):16821. doi: 10.1038/s41598-024-67263-8. Sci Rep. 2024. PMID: 39039143 Free PMC article.
-
An Awareness of Pharmacovigilance Among Healthcare Professionals Due to an Underreporting of Adverse Drug Reactions Issue: A Systematic Review of the Current State, Obstacles, and Strategy.Curr Drug Saf. 2024;19(3):317-331. doi: 10.2174/0115748863276456231016062628. Curr Drug Saf. 2024. PMID: 38989832 Free PMC article.
-
Pharmacovigilance teaching and learning: a mixed cross-sectional analysis of the Portuguese public higher education system.BMC Med Educ. 2024 Jan 3;24(1):13. doi: 10.1186/s12909-023-04963-1. BMC Med Educ. 2024. PMID: 38172845 Free PMC article.
References
-
- Meier F, Maas R, Sonst A, Patapovas A, Muller F, Plank-Kiegele B, Pfistermeister B, Schoffski O, Bürkle T, Dormann H. Adverse drug events in patients admitted to an emergency department:an analysis of direct costs. Pharmacoepidemiol Drug Saf. 2015;24(2):176–186. doi: 10.1002/pds.3663. - DOI - PubMed
-
- Wiffen P, Gill M, Edwards J, Moore A. Adverse drug reactions in hospital patients. A systematic review of the prospective and retrospective studies. Bandolier Extra. 2002:1–16.
-
- Beijer HJM, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR):a meta-analysis of observational studies. Pharm World Sci. 2002;24(2):46–54. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous